3653 results for «358»

Filter By

3653 results

Challenging STEMI scenarios - Part 1

11 Dec 2025 – From GulfPCR-GIM 2025

This session addresses challenging STEMI scenarios with a focus on atypical presentations, complex complications, and advanced management strategies. Through diverse case discussions, it highlights approaches to overcome procedural difficulties, manage large thrombus burdens, and avoid clinical pitfalls in acute STEMI care.

Challenging STEMI scenarios - Part 1

Redo TAVI for transcatheter heart valve failure

18 Nov 2025 – From PCR London Valves 2025

This session addresses the critical considerations involved in re-do TAVI procedures for transcatheter heart valve failure. It guides through key decision-making processes, step-by-step CT analysis for procedural planning, and established protocols to effectively execute valve-in-valve interventions, enhancing outcomes in complex repeat valve therapies.

Redo TAVI for transcatheter heart valve failure

Transcatheter mitral valve replacement in practice

18 Nov 2025 – From PCR London Valves 2025

This session provides an in-depth overview of transcatheter mitral valve replacement (TMVR) in clinical practice, focusing on patient and anatomical suitability assessments including imaging parameters and risk factors for left ventricular outflow tract obstruction. It covers anatomical preparation techniques such as leaflet modification, prior clip removal,...

Transcatheter mitral valve replacement in practice

Tricuspid repair or replacement - Matching the patient to the procedural strategy

17 Nov 2025 – From PCR London Valves 2025

This session addresses the nuanced decision-making process in selecting appropriate transcatheter tricuspid repair or replacement strategies. It covers the current device landscape, patient selection criteria based on anatomical and clinical factors, and discusses emerging challenges such as pacing lead management, anticoagulation, and outcome definitions.

Tricuspid repair or replacement - Matching the patient to the procedural strategy

Calcified lesions: LIVE Educational Case from King Faisal Cardiac Center, National Guard Health Affairs- Western region - Jeddah, Saudi Arabia

11 Dec 2025 – From GulfPCR-GIM 2025

This educational session from King Faisal Cardiac Center provides a detailed examination of optimal device use in calcified coronary lesions, emphasizing the role of intracoronary imaging to improve PCI results and patient outcomes. It also offers guidance on selecting appropriate strategies for coronary bifurcation lesions through...

Calcified lesions: LIVE Educational Case from King Faisal Cardiac Center, National Guard Health Affairs- Western region - Jeddah, Saudi Arabia

Alain Cribier EuroIntervention Award

16 Nov 2025 – From PCR London Valves 2025

This session honors the legacy and contributions of Alain Cribier through the EuroIntervention Award, recognizing excellence and innovation in interventional cardiology. It reflects on the advancements inspired by Dr. Cribier's pioneering work and highlights key achievements in the field.

Alain Cribier EuroIntervention Award

Special Recognition Award Ceremony

17 Nov 2025 – From PCR London Valves 2025

The Special Recognition Award Ceremony honors outstanding achievements and contributions within the field of cardiology. This distinguished event celebrates excellence, innovation, and dedication, acknowledging individuals and teams who have significantly advanced interventional cardiology and patient care.

Special Recognition Award Ceremony

Innovation and teamwork in structural heart interventions

11 Dec 2025 – From GulfPCR-GIM 2025

This session explores innovations and collaborative approaches in structural heart interventions, focusing on aortic and mitral valve procedures. It addresses procedural indications, challenges, and the evolving roles of non-physician allied professionals. Interactive elements foster knowledge exchange and support the growth of expertise in the structural heart...

Innovation and teamwork in structural heart interventions

SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk

07 Nov 2021

Although TAVI is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about long-term comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. P. Redaelli & M. Pighi review the SURTAVI trial...

Paola Redaelli

Author

Paola Redaelli
M. Pighi

Author

Michele Pighi
SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk

World Heart Day 2023: Reducing the burden of cardiovascular disease globally: beyond stents and balloons!

29 Sep 2023

Global burden of Cardiovascular Disease

Cardiovascular disease (CVD) remains the lead cause of mortality for men and women globally. Our world population in 2023 is 8 billion! Of these, around 620 million people are living with heart and circulatory diseases across the world. Each year around 60...

Vijay Kunadian

Author

Vijay Kunadian
World Heart Day 2023

The Lancet Commission to reduce global burden of cardiovascular disease in women by 2030

29 Aug 2021

Vijay Kunadian summarizes the key points of the LBT session of the ESC congress 2021 held on Sunday, 29 August focusing on the Lancet Commission to reduce the global burden of heart disease in women by 2030.

Vijay Kunadian

Author

Vijay Kunadian
ESC Congress 2021 - Global burden of cardiovascular disease in women; 20/20 vision for 2030: report of The Lancet commission

BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

07 Nov 2022

Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.

This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...

Nicola Ryan

Author

Nicola Ryan
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions

08 Jan 2025

In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.

Author

Bruno Scheller
Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions
Didn’t find what you were looking for?